Approaches to treatment of patients with uric acid dysmetabolism
- 作者: Scherbak A.V1, Lebedeva M.V1
-
隶属关系:
- 期: 编号 2 (2014)
- 页面: 39-41
- 栏目: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/262561
- ID: 262561
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
Approaches to medical treatment of uric acid dymetabolism are discussed. Clinical case, illustrating the efficacy of most widely used therapeutical schemes are presented. Indications for use of drugs, inducing the salvation of uric acid in the urine are named; methods of prevention of uric acid crystallization in urinary tract are reviwed.
全文:
参考
- Мухин Н.А., Фомин В.В., Лебедева М.В. Гиперурикемия как компонент кардиоренального синдрома // Терапевтический архив. - 2011. - № 6. - С. 5-12.
- Hunsicker L.G., Adler S., Caggiula A. et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study // Kidney Int. - 1997. - Vol. 51. - P. 1908.
- Лебедева М.В., Балкаров И.М., Мухин Н.А. Ранняя диагностика уратного поражения почек // Терапевтический архив. - 1997. - № 6. - С. 56-59.
- Suresh E., Das P. Recent advances in management of gout // QJM. - 2012. - Vol. 105(5). - P. 407-17.
- Yamanaka H. Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: second edition // Nucleotides Nucleic Acids. - 2011. - Vol. 30. - P. 1018.
- Мухин Н.А., Балкаров И.М., Моисеев С.В. и др. Урикозурическое действие лозартана // Клиническая фармакология и терапия. - 2003. - № 5. - С 55-58.
- Burns C. M., Wortmann R.L. Latest evidence on gout management: what the clinician needs to know // Ther Adv Chronic Dis. - 2012. - Vol. 3(6). - P. 271-286.
- Балкаров И.М., Щербак А.В., Лебедева М.В. и др. Уратная нефропатия в семьях больных подагрой // Клиническая геронтология. - 2005. - № 11(4). - С. 42-46.
- Anzai N., Enomoto A., Renal urate handling: clinical relevance of recent advances // PloS Genet. - 2009. - Vol. 5(6). - P. e1000504.
- Xu H., Zisman A.L., Coe F.L. et al. Kidney stones: an update on current pharmacological management and future directions // Expert Opin Pharmacother. - 2013. - Vol. 14(4). - P. 435-447.
- Trinchieri A., Esposito N., Castelnuovo C. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate // Arch. Ital. Urol. Androl - 2009. - Vol. 81. - P. 188.
- Gaffo A.L., Saag K.G. Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout // Core Evid. - 2010. - Vol. 15;4. - P. 25-36.
补充文件
